You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
貝康醫療(2170.HK)漲超9% 為連續第五日上漲
格隆匯 04-22 12:33
格隆匯4月22日丨近日表現強勢的貝康醫療(2170.HK)今日漲勢繼續,且盤中漲幅進一步擴大,半日收漲9.38%報23.9港元,該股已連漲5日,最新市值65億港元。貝康醫療是中國輔助生殖基因檢測解決方案最領先的創新平台,也是中國唯一一家擁有覆蓋整個生殖週期的基因檢測試劑盒產品線的公司,被稱為港股NGS基因檢測第一股。4月14日,央行官網發佈工作論文《關於我國人口轉型的認識和應對之策》指出,應全面放開和鼓勵生育,切實解決婦女在懷孕、生產、入托、入學中的困難,綜合施策,久久為功,努力實現2035 年遠景規劃和百年奮鬥目標。行業內從業人員表示,“全面放開和鼓勵生育”的政策將促使整個生殖健康產業鏈的需求量大幅提升,給相關的行業和企業帶來巨大的發展機遇。公司日前因此,股價持續多日走強。還值得注意的是,貝康醫療此前還與蘇州BioX生命智能產業研究院簽署成果轉化協議,雙方明確將在遺傳病與人工智能方向開展戰略合作,全方位推動生殖健康與人工智能“產學研”合作和成果轉化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account